These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2903914)

  • 1. Glycine potentiates strychnine-induced convulsions: role of NMDA receptors.
    Larson AA; Beitz AJ
    J Neurosci; 1988 Oct; 8(10):3822-6. PubMed ID: 2903914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
    Singh L; Oles RJ; Tricklebank MD
    Br J Pharmacol; 1990 Feb; 99(2):285-8. PubMed ID: 1691674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine potentiates NMDA responses in rat hippocampal CA1 neurons.
    Minota S; Miyazaki T; Wang MY; Read HL; Dun NJ
    Neurosci Lett; 1989 May; 100(1-3):237-42. PubMed ID: 2569702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning.
    Chiamulera C; Costa S; Reggiani A
    Psychopharmacology (Berl); 1990; 102(4):551-2. PubMed ID: 1982904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties.
    Sheardown MJ; Drejer J; Jensen LH; Stidsen CE; Honoré T
    Eur J Pharmacol; 1989 Dec; 174(2-3):197-204. PubMed ID: 2560979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine potentiates the NMDA response in cultured mouse brain neurons.
    Johnson JW; Ascher P
    Nature; 1987 Feb 5-11; 325(6104):529-31. PubMed ID: 2433595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.
    Birch PJ; Grossman CJ; Hayes AG
    Eur J Pharmacol; 1988 Sep; 154(1):85-7. PubMed ID: 2846328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    Verdoorn TA; Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Mar; 35(3):360-8. PubMed ID: 2564633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.
    Henzi V; Reichling DB; Helm SW; MacDermott AB
    Mol Pharmacol; 1992 Apr; 41(4):793-801. PubMed ID: 1349155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allosteric glycine site of the N-methyl-D-aspartate receptor modulates GABAergic-mediated synaptic events in neonatal rat CA3 hippocampal neurons.
    Gaiarsa JL; Corradetti R; Cherubini E; Ben-Ari Y
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):343-6. PubMed ID: 2153293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of non-NMDA receptors inhibits handling-induced, strychnine-potentiated convulsions.
    McAllister KH
    Eur J Pharmacol; 1993 Feb; 231(2):309-12. PubMed ID: 8384115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique.
    Mayer ML; Westbrook GL; Vyklický L
    J Neurophysiol; 1988 Aug; 60(2):645-63. PubMed ID: 2902200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor.
    Birch PJ; Grossman CJ; Hayes AG
    Eur J Pharmacol; 1988 Oct; 156(1):177-80. PubMed ID: 2905271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartic acid/glycine interactions on the control of 5-hydroxytryptamine release in raphe primary cultures.
    Becquet D; Héry M; Deprez P; Faudon M; Fache MP; Giraud P; Héry F
    J Neurochem; 1993 Nov; 61(5):1692-7. PubMed ID: 7901329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
    Stasheff SF; Anderson WW; Clark S; Wilson WA
    Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate.
    Raigorodsky G; Urca G
    Eur J Pharmacol; 1990 Jun; 182(1):37-47. PubMed ID: 1976097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
    Reynolds IJ; Harris KM; Miller RJ
    Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo.
    Danysz W; Wroblewski JT; Brooker G; Costa E
    Brain Res; 1989 Feb; 479(2):270-6. PubMed ID: 2538209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
    Mount H; Quirion R; Chaudieu I; Boksa P
    Mol Pharmacol; 1991 Feb; 39(2):205-10. PubMed ID: 1825345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.